Want to see KR:077500 full AI Analyst Report?
Uniquest Corporation (077500) AI Stock Analysis
Uniquest Corporation
(Korea Exchange:077500)
The score is held back primarily by weak cash flow and higher leverage despite improved reported earnings, which increases financial risk. Offsetting this, technical momentum is strong (price above key moving averages with positive MACD) and valuation appears attractive given the low P/E and moderate dividend yield.
Uniquest Corporation (077500) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- KRW 240.41B
- Dividend Yield
- 1.80%
- Average Volume (3M)
- 394.46K
- Price to Earnings (P/E)
- 7.9
- Beta (1Y)
- 0.56
- Revenue Growth
- 9.12%
- EPS Growth
- 398.65%
- Country
- KR
- Employees
- 248
- Sector
- General
- Sector Strength
- 55
- Industry
- Technology Distributors
Uniquest Corporation Business Overview & Revenue Model
Company Description
Uniquest Corporation operates as an international distributor of electronic components, with operations spanning South Korea and global markets. The company's extensive product portfolio encompasses advanced 3D multimedia, sensor, and wireless techno...
Uniquest Corporation Financial Statement Overview
Summary
Revenue and profitability improved in TTM (income statement score 68), but overall quality is heavily dragged by a sharp deterioration in cash generation (cash flow score 27 with deeply negative operating/free cash flow) and a meaningful increase in leverage (balance sheet score 54 with higher debt-to-equity).
Income Statement
68PositiveBalance Sheet
54NeutralCash Flow
27Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 773.62B | 730.04B | 710.48B | 665.93B | 739.46B | 590.98B |
| Gross Profit | 80.05B | 69.48B | 66.81B | 62.50B | 77.03B | 57.82B |
| EBITDA | 45.00B | 36.29B | 36.58B | 37.23B | 38.13B | 81.72B |
| Net Income | 30.26B | 20.62B | 5.29B | 19.34B | 49.12B | 62.56B |
Balance Sheet | ||||||
| Total Assets | 770.54B | 517.51B | 482.35B | 454.40B | 610.72B | 490.33B |
| Cash, Cash Equivalents and Short-Term Investments | 116.98B | 69.77B | 54.21B | 78.28B | 44.42B | 51.59B |
| Total Debt | 278.01B | 124.60B | 137.88B | 126.78B | 104.21B | 56.96B |
| Total Liabilities | 497.81B | 272.65B | 250.95B | 240.75B | 262.88B | 181.82B |
| Stockholders Equity | 275.00B | 246.83B | 232.06B | 213.97B | 346.07B | 301.74B |
Cash Flow | ||||||
| Free Cash Flow | -123.53B | 32.07B | 1.84B | -8.50B | -47.26B | 7.64B |
| Operating Cash Flow | -122.78B | 32.54B | 2.15B | -4.76B | -46.25B | 9.79B |
| Investing Cash Flow | -8.97B | -4.51B | -3.53B | -19.64B | 9.29B | -13.66B |
| Financing Cash Flow | 146.55B | -13.38B | -11.78B | 23.67B | 31.73B | 8.09B |
Uniquest Corporation Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:077500, the sentiment is Positive. The current price of 11130.00 is above the 20-day moving average (MA) of 10520.00, above the 50-day MA of 8841.20, and above the 200-day MA of 7065.75, indicating a bullish trend. The MACD of 783.09 indicates Negative momentum. The RSI at 57.34 is Neutral, neither overbought nor oversold. The STOCH value of 61.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for KR:077500.
Uniquest Corporation Peers Comparison
Overall Rating
- KR:07750064Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| KR:077500 | 64Neutral | KRW 240.41B | 7.88 | ― | 1.80% | 9.12% | 398.65% |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KR:077500 | Uniquest Corporation | 11130.00 | 3509.81 | 46.06% | |
| KR:038290 | Macrogen, Inc. | 10900.00 | -3847.74 | -26.09% | |
| KR:086890 | ISU Abxis Co., Ltd. | 3435.00 | -1385.00 | -28.73% | |
| KR:331920 | Celemics, Inc. | 9230.00 | 6370.00 | 222.73% | |
| KR:340450 | GC Genome Corp. | 9100.00 | 2080.00 | 29.63% | |
| KR:394420 | RecensMedical, Inc. | 5150.00 | -13300.00 | -72.09% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026